Delphine Loirat Selected Research

Monoclonal Antibodies

1/2022

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Delphine Loirat Research Topics

Disease

18	Triple Negative Breast Neoplasms 04/2024 - 01/2021
17	Breast Neoplasms (Breast Cancer) 05/2024 - 02/2017
17	Neoplasms (Cancer) 02/2024 - 10/2016
5	Brain Neoplasms (Brain Tumor) 05/2024 - 01/2021
4	Disease Progression 04/2024 - 01/2021
3	Circulating Neoplastic Cells 11/2023 - 06/2017
3	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2022
2	Febrile Neutropenia 04/2024 - 01/2021
2	Inflammatory Breast Neoplasms 01/2023 - 12/2021
2	Neutropenia 10/2022 - 01/2021
2	Diarrhea 10/2022 - 01/2021
1	Septic Shock (Toxic Shock Syndrome) 10/2023
1	Colitis 10/2023
1	Fatigue 10/2023
1	Squamous Cell Carcinoma of Head and Neck 11/2021
1	Microsatellite Instability 11/2021
1	Necrosis 01/2021
1	Leukopenia 01/2021
1	Cytopenia 01/2021
1	Anemia 01/2021
1	Adenocarcinoma 05/2020

Drug/Important Bio-Agent (IBA)

8	sacituzumab govitecanIBA 04/2024 - 01/2021
6	Hormones (Hormone)IBA 05/2024 - 01/2021
5	Gemcitabine FDA Link 10/2022 - 01/2021
4	Capecitabine (Xeloda)FDA Link 04/2024 - 01/2021
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2023
4	Carboplatin (JM8)FDA LinkGeneric 01/2024 - 01/2022
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2017
3	pembrolizumabIBA 03/2024 - 01/2022
3	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 01/2021
3	Surface Antigens (Surface Antigen)IBA 02/2024 - 01/2021
3	durvalumabIBA 01/2024 - 11/2023
3	ErbB Receptors (EGF Receptor)IBA 11/2023 - 10/2022
3	olaparibIBA 12/2022 - 01/2021
3	eribulin FDA Link 10/2022 - 01/2021
3	Vinorelbine (Navelbine)FDA LinkGeneric 10/2022 - 01/2021
3	AntigensIBA 10/2022 - 10/2016
2	trastuzumab deruxtecanIBA 05/2024 - 04/2024
2	Trastuzumab (Herceptin)FDA Link 04/2024 - 09/2021
2	human ERBB2 proteinIBA 02/2024 - 01/2024
2	Fulvestrant (Faslodex)FDA Link 02/2024 - 01/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2022 - 01/2021
2	palbociclibIBA 01/2021 - 01/2020
2	Estrogen ReceptorsIBA 01/2021 - 01/2020
1	EnzymesIBA 04/2024
1	tucatinibIBA 04/2024
1	Everolimus FDA Link 02/2024
1	Cell-Free Nucleic AcidsIBA 02/2024
1	veliparibIBA 01/2024
1	taxaneIBA 10/2023
1	atezolizumabIBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2022
1	Poly Adenosine Diphosphate RiboseIBA 12/2022
1	Immunoglobulin IsotypesIBA 10/2022
1	Cyclin-Dependent Kinase 4IBA 10/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Farnesyltranstransferase (Farnesyltransferase)IBA 11/2021
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	tipifarnib (R115777)IBA 11/2021
1	pertuzumabIBA 09/2021
1	LTX-315IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Topoisomerase I InhibitorsIBA 01/2021
1	dimemorfan (AT 17)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	HaptoglobinsIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 12/2020
1	AntibodiesIBA 05/2020
1	Tn antigenIBA 05/2020
1	GlycopeptidesIBA 05/2020
1	VaccinesIBA 05/2020
1	CarbohydratesIBA 05/2020
1	Complement System Proteins (Complement)IBA 05/2020
1	thymidine kinase 1IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	CytokinesIBA 01/2020
1	N(1)- pentadecanoyl- N(3'')- trifluoracetylkanamycin AIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 12/2019
1	abirateroneIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 02/2017
1	Insulin (Novolin)FDA Link 10/2016

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 02/2024 - 01/2018
10	Therapeutics 04/2024 - 01/2018
10	Radiotherapy 03/2024 - 01/2019
5	Immunotherapy 03/2024 - 01/2014
5	Neoadjuvant Therapy 01/2024 - 01/2021
1	Drug Tapering 04/2024
1	Salvage Therapy 01/2023
1	Mastectomy (Mammectomy) 12/2022
1	Segmental Mastectomy (Lumpectomy) 12/2022
1	Radical Mastectomy 12/2022
1	Adjuvant Chemotherapy 06/2022
1	Combination Drug Therapy (Combination Chemotherapy) 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Injections 01/2021